Brii Biosciences Limited (BRIBF)
OTCMKTS · Delayed Price · Currency is USD
0.2406
+0.0094 (4.07%)
At close: Aug 1, 2025
Brii Biosciences Market Cap
Brii Biosciences has a market cap or net worth of $175.22 million as of October 20, 2025. Its market cap has increased by 71.06% in one year.
Market Cap
175.22M
Enterprise Value
-123.69M
Revenue
4.02M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.24
Market Cap Chart
Since July 13, 2021, Brii Biosciences's market cap has decreased from 2.09B to 175.22M, a decrease of -91.60%. That is a compound annual growth rate of -43.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 20, 2025 | 175.22M | 89.91% |
| Dec 31, 2024 | 92.26M | -56.66% |
| Dec 29, 2023 | 212.88M | -69.02% |
| Dec 30, 2022 | 687.16M | -77.39% |
| Dec 31, 2021 | 3.04B | 45.61% |
| Jul 13, 2021 | 2.09B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Glass House Brands | 671.98M |
| Elite Pharmaceuticals | 660.18M |
| Veradigm | 517.28M |
| Northwest Biotherapeutics | 347.69M |
| CytoDyn | 336.10M |
| Nika Pharmaceuticals | 333.67M |
| Silence Therapeutics | 307.02M |
| American Oncology Network | 277.57M |